-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pfizer recently announced that the U.
TBE is a viral infection of the brain and spine that is transmitted to humans through the bite of an infected tick
Although TBE is not endemic in the United States so far, it has been found in more than 35 countries in Europe and Asia
Pfizer's TBE vaccine has been used outside the United States for more than 45 years.
In clinical trials, the safety and immunogenicity of TICOVAC were evaluated in 2 age groups (1-15 years old, >16 years old)
Original source: US FDA Approves TICOVAC™, Pfizer's Tick-Borne Encephalitis (TBE) Vaccine